News from prime therapeutics A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle.

Latest

Oct 29, 2019, 09:00 ET Prime Therapeutics Study Finds Tagrisso® New First-line Lung Cancer Treatment Drives Ten-fold Use, $4 Million Cost Increase

A new study from Prime Therapeutics LLC (Prime) shows a ten-fold increase in the use of osimertinib (Tagrisso®) – an epidermal growth factor receptor ...


May 17, 2019, 09:00 ET Prime Therapeutics earns URAC accreditation in pharmacy benefit management

Prime Therapeutics LLC (Prime) announces it has earned URAC accreditation in Pharmacy Benefit Management (PBM). URAC is the independent leader in...


Apr 11, 2019, 09:00 ET Prime Therapeutics hires Kenneth H. Paulus as president and CEO

Prime Therapeutics LLC (Prime) announced today that its board of directors has selected Kenneth H. Paulus as president and CEO, effective May 7....


Mar 26, 2019, 09:00 ET Prime Therapeutics finds biologic therapy accounts for vast majority of Crohn's disease, ulcerative colitis total cost of care

Two new studies by pharmacy benefit manager (PBM) Prime Therapeutics LLC (Prime), using real-world medical and pharmacy data, show biologic therapy...


Mar 26, 2019, 09:00 ET Prime Therapeutics forecasts cystic fibrosis spending could double in 2019

Recently approved cystic fibrosis (CF) treatments and new approvals for additional ages or mutations could double the spending on CF treatments in...


Mar 26, 2019, 09:00 ET Prime Therapeutics finds members using Botox® to treat migraines didn't stay on the drug, saw substantially higher total migraine cost of care

A real-world study by pharmacy benefit manager (PBM) Prime Therapeutics LLC (Prime), found while most Botox® (onabotulinumToxinA) use is for chronic...


Mar 26, 2019, 09:00 ET Study shows Prime Therapeutics NetResults™ exclusion formulary doesn't lead to more medical use or higher costs

Prime Therapeutics LLC (Prime), a pharmacy benefit manager (PBM) serving more than 28 million Blue Cross and Blue Shield members nationally, recently ...


Mar 26, 2019, 09:00 ET Prime Therapeutics finds gene therapy treatment for rare spinal muscular atrophy (SMA) disease may significantly impact costs

Pharmacy benefit manager (PBM) Prime Therapeutics LLC (Prime) forecasts the financial impact of a new gene therapy treatment potentially coming this...


Mar 04, 2019, 09:00 ET Prime Therapeutics launches Specialty Monitor™ to deliver total drug management insights

Prime Therapeutics LLC (Prime), a pharmacy benefit manager (PBM) serving 23 Blue Cross and Blue Shield plans nationally, recently launched Specialty...


Dec 18, 2018, 10:30 ET Prime Therapeutics Recognized Again for Two NCQA Programs: Certification for Health Information Products - Pharmacy Benefit Information plus Accreditation for Utilization Management

Prime Therapeutics LLC (Prime), a leading pharmacy benefit manager (PBM) with more than 27 million members, will continue its National Committee for...


Oct 24, 2018, 09:00 ET Prime Therapeutics' diabetes drug therapy study: Multi-stakeholder improvement needed to help patients stay on, use most clinically appropriate drugs to prevent cardiovascular events

Pharmacy benefit manager Prime Therapeutics LLC (Prime) recently analyzed both medical and pharmacy claims to identify members with diabetes and the...


Oct 23, 2018, 16:15 ET Prime Therapeutics finds different predictive models are needed to identify future high-risk prescription opioid use for new versus current opioid users

To help combat misuse and abuse of prescription opioids, pharmacy benefit manager Prime Therapeutics LLC (Prime) recently developed a new predictive...


Oct 23, 2018, 13:30 ET Providing Opioid Safety Guide at the pharmacy counter associated with four-fold increase in overdose reversal drug dispensing

Florida Blue, Prime Therapeutics LLC (Prime) and Walgreens piloted a program where Walgreens pharmacists gave a one-page Opioid Safety Guide to...


Jun 04, 2018, 09:00 ET Prime Therapeutics Expands its Fraud, Waste, Abuse Detection to Include Prescribers, Patients

To significantly reduce fraud, waste and abuse (FWA) that occurs with prescription drug claims, Prime Therapeutics LLC (Prime), a pharmacy benefit...


May 16, 2018, 09:15 ET Two Prime Therapeutics Programs Associated with Improved Adherence for Medicare Members Using Cholesterol, Diabetes and Hypertension Drugs

Prime Therapeutics LLC (Prime), a pharmacy benefit manager serving more than 27 million members nationwide, found lowering a member's cost share for...


Apr 20, 2018, 08:00 ET Prime Therapeutics Finds Costs Double When Switching to New Extended Half-Life Hemophilia Factor Products

An analysis of real-world, integrated pharmacy and medical claims by pharmacy benefit manager (PBM) Prime Therapeutics LLC (Prime) reveals the cost...


Apr 19, 2018, 03:00 ET Prime Therapeutics Finds Drug Costs Drive Nearly Entire Cost of Care for Hereditary Angioedema

The cost of specialty medicines to treat someone with hereditary angioedema (HAE) – a rare genetic disorder that results in potentially...


Mar 07, 2018, 07:00 ET Prime Therapeutics Receives PBMI's Excellence Award

Pharmacy Benefit Management Institute (PBMI) presented Prime Therapeutics LLC (Prime), a leading pharmacy benefit manager (PBM) with more than 27...


Feb 27, 2018, 11:45 ET Prime Therapeutics Surpasses 1 Million Medicaid Members

More than 1 million Medicaid members now make up a significant portion of Prime Therapeutics' (Prime's) total membership of more than 27 million...


Jan 29, 2018, 09:28 ET Prime Therapeutics and Boehringer Ingelheim Enter Into Outcomes-Based Contract for Jardiance®

As part of its CareCentered ContractingTM program, pharmacy benefit manager (PBM) Prime Therapeutics LLC (Prime) recently entered into an...


Dec 01, 2017, 08:00 ET Prime Therapeutics Signs CareCentered Contract™ with leading manufacturer of Multiple Sclerosis drugs

Given the growing use and cost of multiple sclerosis (MS) medicines, Prime Therapeutics LLC (Prime), a leading pharmacy benefit manager (PBM), and...


Jul 17, 2017, 12:15 ET Prime Therapeutics Launches Comprehensive Program to Address Opioid and Controlled Substance Epidemic

A comprehensive program announced today by pharmacy benefit manager Prime Therapeutics LLC (Prime), which serves 14 Blue Cross and Blue Shield plans...


Sep 30, 2016, 11:35 ET Prime Therapeutics Finds Autoimmune Specialty Drug Spend has Doubled, Accounts for 10 Percent of Drug Expenses

In the past four years, spending on autoimmune drugs has doubled and utilization has jumped nearly 40 percent in a population of 4.4 million...


Apr 20, 2016, 10:00 ET Prime Therapeutics Research Finds Increase in Insulin Use, Pharmacy Expense

Prime Therapeutics LLC (Prime), a pharmacy benefit manager serving nearly 26 million members nationally, recently conducted two diabetes studies to...


Apr 19, 2016, 10:00 ET Prime Therapeutics Releases Studies on Efforts to Reduce Opioid Abuse, Misuse

Two new studies presented this week by pharmacy benefit manager Prime Therapeutics LLC (Prime) at the Academy of Managed Care Pharmacy (AMCP) annual...